|
|
Article: Medical Research At a Crossroads Turns Toward Proteins.(several startup companies receive funding for proteomics research)
- Article from:
- San Diego Business Journal
- Article date:
- September 25, 2000
- Author:
CopyrightCOPYRIGHT 2000 CBJ, L.P. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Proteomics Poised to Become Billion-Dollar Business
Now that scientists have determined the complete sequence of human DNA, research teams are preparing for a follow-up project many say will be even more ambitious.
The study of proteins, which proteins are in which cell and how they interact with each other, is heralded as the key to new medicines. "Genes are great, but they don't directly determine disease," said Stefan Unger, an analyst at Frost & Sullivan in San Jose. "In order to cure or detect most diseases, one needs to understand proteins, their interactions and biochemical pathways."
Frost & Sullivan consults health care companies, among ...